QuidelOrtho Corp
Financial highlights
| Metric | FY 12/28/25 | FY 12/29/24 | FY 12/31/23 | FY 01/01/23 | FY 01/02/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.7B | $2.8B | $3.0B | $3.3B | $1.7B |
| Selling, general & administrative | $746.3M | $766.8M | $763.2M | $621.0M | $239.6M |
| Research and development | $186.2M | $218.7M | $245.0M | $187.9M | $95.7M |
| Operating income | -$919.2M | -$2.0B | $139.1M | $843.7M | $906.0M |
| Interest expense | $177.6M | $163.5M | $147.6M | $75.7M | — |
| Pretax income | -$1.1B | -$2.1B | -$29.1M | $735.9M | $900.3M |
| Income tax expense | $24.1M | -$79.5M | -$19.0M | $187.2M | $196.1M |
| Net income | -$1.1B | -$2.1B | -$10.1M | $548.7M | $704.2M |
| Balance Sheet | |||||
| Cash and equivalents | $169.8M | $98.3M | $118.9M | $292.9M | $802.8M |
| Current assets | $1.4B | $1.2B | $1.3B | $1.6B | $1.4B |
| Total assets | $5.8B | $6.4B | $8.6B | $8.9B | $2.4B |
| Current liabilities | $966.1M | $998.8M | $833.8M | $1.0B | $323.5M |
| Total liabilities | $3.8B | $3.4B | $3.6B | $3.9B | $501.0M |
| Total debt | $2.7B | $2.5B | $2.4B | $2.6B | $400,000 |
| Stockholders' equity | $1.9B | $3.0B | $5.0B | $4.9B | $1.9B |
| Cash Flow Statement | |||||
| Cash from operations | $105.2M | $83.0M | $280.2M | $885.3M | $805.9M |
| Depreciation and amortization | $442.0M | $453.4M | $457.2M | $283.6M | $52.7M |
| Stock-based compensation | $45.9M | $42.1M | $51.6M | $48.4M | $25.4M |
| Capital expenditure | $188.2M | $195.1M | $209.3M | $140.9M | $292.8M |
| Free cash flow | -$83.0M | -$112.1M | $70.9M | $744.4M | $513.1M |
| Share repurchases | $0 | $0 | $7.2M | $74.3M | $103.5M |
| Impairments | $700.7M | $1.8B | $0 | $0 | — |
Shares outstanding 68.2M · Free float 81.3%
Annual filing data through FY ended December 28, 2025; float as of July 16, 2026.